Charles River Laboratories International (CRL) News Today $165.56 -1.43 (-0.85%) As of 10:28 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Sei Investments Co.Sei Investments Co. boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 673,868 shares of the medical research company's stock after purchasing an additional 38,827March 24 at 5:34 AM | marketbeat.comiA Global Asset Management Inc. Has $360,000 Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)iA Global Asset Management Inc. cut its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 91.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,950 shares of the medicMarch 24 at 4:42 AM | marketbeat.comThe Goldman Sachs Group Downgrades Charles River Laboratories International (NYSE:CRL) to NeutralMarch 24 at 2:29 AM | americanbankingnews.comEnvestnet Portfolio Solutions Inc. Reduces Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Envestnet Portfolio Solutions Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,203 shares of the medical researMarch 23 at 3:44 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Stock Rating Lowered by The Goldman Sachs GroupThe Goldman Sachs Group lowered shares of Charles River Laboratories International from a "buy" rating to a "neutral" rating and cut their target price for the stock from $190.00 to $170.00 in a research report on Friday.March 22 at 8:18 AM | marketbeat.comCharles River Labs (CRL) was downgraded to a Hold Rating at Goldman SachsMarch 21, 2025 | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Stock Price Down 3.4% - Time to Sell?Charles River Laboratories International (NYSE:CRL) Stock Price Down 3.4% - Here's WhyMarch 21, 2025 | marketbeat.com3 Reasons CRL is Risky and 1 Stock to Buy InsteadMarch 20, 2025 | msn.comInvestment House LLC Has $12.05 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Investment House LLC reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 65,265 shares of the medical research company's stock after selling 3,041March 20, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Stokes Family Office LLCStokes Family Office LLC decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor ownedMarch 20, 2025 | marketbeat.comNatixis Advisors LLC Lowers Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Natixis Advisors LLC cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 78,439 shares of the medical research company's stock aMarch 20, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Sequoia Financial Advisors LLCSequoia Financial Advisors LLC cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 79.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,962 shares of the medical researcMarch 19, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Short Interest Up 26.3% in FebruaryCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 2,930,000 shares, an increase of 26.3% from the February 13th total of 2,320,000 shares. Currently, 5.8% of the shares of the company are short sold. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is presently 2.9 days.March 18, 2025 | marketbeat.comIs Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?March 18, 2025 | uk.finance.yahoo.comHorizon Kinetics Asset Management LLC Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)Horizon Kinetics Asset Management LLC decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 47.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investorMarch 18, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stake Cut by Swiss National BankSwiss National Bank reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,900 shares of theMarch 18, 2025 | marketbeat.comZacks Research Has Pessimistic Outlook of CRL Q1 EarningsMarch 18, 2025 | americanbankingnews.comZacks Research Has Negative Outlook of CRL Q1 EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Zacks Research lowered their Q1 2025 earnings per share estimates for Charles River Laboratories International in a research note issued on Wednesday, March 12th. Zacks Research analyst R. Department now expects that the meMarch 17, 2025 | marketbeat.comTredje AP fonden Has $738,000 Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Tredje AP fonden reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,996 shares of the medMarch 16, 2025 | marketbeat.comProficio Capital Partners LLC Takes $10.77 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Proficio Capital Partners LLC acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 58,334 shares of the medical reMarch 16, 2025 | marketbeat.comWhat is Zacks Research's Forecast for CRL FY2027 Earnings?March 16, 2025 | americanbankingnews.comFY2027 Earnings Estimate for CRL Issued By Zacks ResearchCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Investment analysts at Zacks Research issued their FY2027 EPS estimates for shares of Charles River Laboratories International in a report released on Wednesday, March 12th. Zacks Research analyst R. Department forecasts thMarch 15, 2025 | marketbeat.comImpact Capital Partners LLC Acquires Shares of 2,287 Charles River Laboratories International, Inc. (NYSE:CRL)Impact Capital Partners LLC acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 2,287 shares of thMarch 15, 2025 | marketbeat.comAmundi Buys 16,599 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Amundi raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 70,266 shares of the medical research company's stock afMarch 15, 2025 | marketbeat.comPNC Financial Services Group Inc. Purchases 2,916 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)PNC Financial Services Group Inc. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 25.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,278 sharMarch 15, 2025 | marketbeat.com231,720 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 231,720 shares of the medicaMarch 13, 2025 | marketbeat.comCharles River Laboratories International Q4 Earnings TranscriptMarch 12, 2025 | marketbeat.comCooke & Bieler LP Purchases 126,372 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Cooke & Bieler LP lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 42.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 426,767 shares of the medical research companMarch 12, 2025 | marketbeat.comKing Luther Capital Management Corp Cuts Position in Charles River Laboratories International, Inc. (NYSE:CRL)King Luther Capital Management Corp lessened its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 20.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,343 sMarch 12, 2025 | marketbeat.comJohnson Investment Counsel Inc. Has $3.68 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Johnson Investment Counsel Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 8.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,942 shares of the medical research compaMarch 11, 2025 | marketbeat.comAssetmark Inc. Has $1.80 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Assetmark Inc. increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5,099.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,775 shares of the medical research company's stock afterMarch 11, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Keybank National Association OHKeybank National Association OH decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 51.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor ownedMarch 11, 2025 | marketbeat.comOFI Invest Asset Management Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)OFI Invest Asset Management acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acqMarch 10, 2025 | marketbeat.comEdgestream Partners L.P. Purchases New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Edgestream Partners L.P. purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 12,880 shares of the medical research company's stock, valued at aMarch 10, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Charles Schwab Investment Management Inc. boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 7.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 552,975 shares of the medicMarch 10, 2025 | marketbeat.comE Fund Management Co. Ltd. Invests $336,000 in Charles River Laboratories International, Inc. (NYSE:CRL)E Fund Management Co. Ltd. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,820 shareMarch 9, 2025 | marketbeat.comAtria Investments Inc Trims Position in Charles River Laboratories International, Inc. (NYSE:CRL)Atria Investments Inc lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 12.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,869 shares of theMarch 9, 2025 | marketbeat.comVictory Capital Management Inc. Has $60.17 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Victory Capital Management Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 325,947 shares of the medical researcMarch 8, 2025 | marketbeat.comUS Bancorp DE Lowers Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)US Bancorp DE reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 33.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,148 shares of the medical research company's stock after sMarch 8, 2025 | marketbeat.comVestmark Advisory Solutions Inc. Decreases Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Vestmark Advisory Solutions Inc. decreased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 8.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 23,568 shares of the medical research company's stock aMarch 7, 2025 | marketbeat.comGeneva Capital Management LLC Sells 2,026 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Geneva Capital Management LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,790 shares of the medical researcMarch 7, 2025 | marketbeat.comCullen Frost Bankers Inc. Sells 2,391 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Cullen Frost Bankers Inc. reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 19,282 shares of the mediMarch 7, 2025 | marketbeat.comSpotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4March 5, 2025 | uk.finance.yahoo.comCharles River, LabCorp upgraded, Quest downgraded at Citi on valuationMarch 4, 2025 | msn.comCitigroup Upgrades Charles River Laboratories International (CRL)March 4, 2025 | msn.comCharles River upgraded to Neutral from Sell at CitiMarch 4, 2025 | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Rating Increased to Neutral at CitigroupCitigroup raised shares of Charles River Laboratories International from a "sell" rating to a "neutral" rating and increased their price objective for the company from $155.00 to $175.00 in a research report on Tuesday.March 4, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Flputnam Investment Management Co.Flputnam Investment Management Co. reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 50.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,962 shares of the mediMarch 4, 2025 | marketbeat.comFairJourney Biologics Acquires Charles River Laboratories South San Francisco FacilityMarch 4, 2025 | businesswire.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Reduce" from BrokeragesShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been assigned a consensus rating of "Reduce" from the sixteen brokerages that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, thirteen haMarch 4, 2025 | marketbeat.com Remove Ads Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.520.63▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼179▲CRL Articles Average Week Remove Ads Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRL Stock Free CRL Stock Alerts